Skip to main content

M161 M161 (Didanosine Delayed Release 250 mg)

Pill with imprint M161 M161 is Yellow, Capsule-shape and has been identified as Didanosine Delayed Release 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Didanosine is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M161 M161

Didanosine delayed release 250 mg M161 M161

Didanosine Delayed Release

Imprint
M161 M161
Strength
250 mg
Color
Yellow
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (nrtis)
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-8888 (Discontinued)
Inactive Ingredients
ferrosoferric oxide, carboxymethylcellulose sodium, silicon dioxide, diethyl phthalate, gelatin, hypromelloses, methacrylic acid - methyl methacrylate copolymer (1:1), propylene glycol, ferric oxide red, shellac, trisodium citrate dihydrate, sodium lauryl sulfate, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide, ferric oxide yellow, potassium hydroxide, ammonia

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M161 M161"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.